Drugs / Tumour Infiltrating Lymphocytes
last change Jul 2015 re-read 2 minutes ago

Tumour Infiltrating Lymphocytes

Cell therapy

Developed for
metastatic melanoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01995344 Comparator Mar 2014 → Jul 2015 metastatic melanoma The Christie NHS Foundation Trust Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tumour Infiltrating Lymphocytes ClinicalTrials.gov intervention name — accepted as the source's own label NCT01995344
Modality Cell therapy “Adoptive Cellular Therapy With Tumour Infiltrating Lymphocytes” NCT01995344